These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer. Le Chevalier T Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960 [TBL] [Abstract][Full Text] [Related]
4. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA. Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785 [No Abstract] [Full Text] [Related]
5. The role of pemetrexed in the treatment of colorectal cancer. Hochster H Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812 [TBL] [Abstract][Full Text] [Related]
6. Pemetrexed in the treatment of selected solid tumors. Adjei AA Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793 [TBL] [Abstract][Full Text] [Related]
7. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998. Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578 [No Abstract] [Full Text] [Related]
8. Pemetrexed in bladder, head and neck, and cervical cancers. Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815 [TBL] [Abstract][Full Text] [Related]
16. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Walling J Invest New Drugs; 2006 Jan; 24(1):37-77. PubMed ID: 16380836 [No Abstract] [Full Text] [Related]